CME Group Inc. (CME) Earnings History
Growth Compounder26 years of earnings data (2000–2025) · Consistent double-digit EPS growth over 5 years
Loading earnings history...
CME Group Inc. (CME) Earnings Overview
As of June 21, 2026, CME Group Inc. (CME) reported trailing twelve-month net income of $4.24B, reflecting +15.4% year-over-year growth. The company earned $11.68 per diluted share over the past four quarters, with a net profit margin of 62.0%.
Looking at the long-term picture, CME's 5-year EPS compound annual growth rate (CAGR) stands at +13.7%, showing solid earnings momentum. The company achieved its highest annual net income of $4.06B in fiscal 2017.
CME Group Inc. maintains industry-leading profitability with a gross margin of 86.1%, operating margin of 64.9%, and net margin of 62.0%. This margin structure demonstrates strong pricing power and operational efficiency. View revenue history →
Compared to peers including ICE ($3.30B net income, 26.1% margin), CBOE ($1.10B net income, 23.3% margin), NDAQ ($1.91B net income, 21.8% margin), CME has outperformed on profitability metrics. Compare CME vs ICE →
CME Earnings vs Peers
Earnings metrics vs comparable public companies
CME Historical Earnings Data (2000–2025)
26 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $4.04B | +14.7% | $4.23B | $11.16 | 62.0% | 64.9% |
| 2024 | $3.53B | +9.3% | $3.93B | $9.67 | 57.5% | 64.1% |
| 2023 | $3.23B | +19.9% | $3.44B | $8.86 | 57.8% | 61.6% |
| 2022 | $2.69B | +2.1% | $3.02B | $7.40 | 53.6% | 60.1% |
| 2021 | $2.64B | +25.2% | $2.65B | $7.29 | 56.2% | 56.4% |
| 2020 | $2.11B | -0.5% | $2.64B | $5.87 | 43.1% | 54.0% |
| 2019 | $2.12B | +7.9% | $2.59B | $5.91 | 43.5% | 53.2% |
| 2018 | $1.96B | -51.7% | $2.61B | $5.71 | 45.5% | 60.5% |
| 2017 | $4.06B | +164.9% | $2.31B | $11.94 | 111.5% | 63.4% |
| 2016 | $1.53B | +23.0% | $2.20B | $4.53 | 42.7% | 61.2% |
| 2015 | $1.25B | +10.6% | $1.99B | $3.69 | 37.5% | 59.8% |
| 2014 | $1.13B | +15.4% | $1.77B | $3.35 | 36.2% | 56.8% |
| 2013 | $977M | +9.0% | $1.64B | $2.92 | 33.3% | 55.8% |
| 2012 | $896M | -50.5% | $1.69B | $2.70 | 30.8% | 58.1% |
| 2011 | $1.81B | +90.5% | $2.02B | $5.43 | 55.2% | 61.6% |
| 2010 | $951M | +15.2% | $1.83B | $2.86 | 31.7% | 61.0% |
| 2009 | $826M | +15.4% | $1.59B | $2.48 | 31.6% | 60.8% |
| 2008 | $715M | +8.6% | $1.58B | $2.43 | 27.9% | 61.8% |
| 2007 | $659M | +61.7% | $1.05B | $2.99 | 37.5% | 59.8% |
| 2006 | $407M | +32.7% | $621M | $2.32 | 37.4% | 57.0% |
| 2005 | $307M | +39.8% | $478M | $1.76 | 34.5% | 53.7% |
| 2004 | $220M | +79.8% | $355M | $1.28 | 30.4% | 49.3% |
| 2003 | $122M | +29.8% | $206M | $0.72 | 22.8% | 38.5% |
| 2002 | $94M | +37.7% | $176M | $0.63 | 20.1% | 37.6% |
| 2001 | $68M | +1255.9% | $124M | $0.47 | 17.2% | 31.2% |
| 2000 | -$6M | - | -$8M | $-0.04 | -2.6% | -3.6% |
Download Data
Export CME earnings history in CSV or JSON format
Free sign-in required to download data
Full Stock Analysis
Deep dive into CME consensus models and risk factors.
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
26+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
CME — Frequently Asked Questions
Quick answers to the most common questions about buying CME stock.
What is CME earnings per share (EPS)?
CME trailing twelve-month (TTM) diluted EPS is $11.68, reflecting +15.4% year-over-year growth. The 5-year EPS CAGR is +13.7%. Complete EPS history from 2000 to 2025 is available in the table on this page.
What is CME Group Inc.'s net income?
CME Group Inc. (CME) trailing twelve-month net income is $4.2B as of 2025. Earnings grew +15.4% year-over-year. CME Group Inc. has been profitable for 25 consecutive years.
Is CME profitable?
Yes, CME is profitable with a TTM net income of $4.2B and a net profit margin of +62.0%. CME Group Inc. has generated profits for 25 consecutive years.
What is CME's earnings growth rate?
CME compound annual EPS growth rates (CAGR): 1-Year: +15.4%, 3-Year: +14.7%, 5-Year: +13.7%, 10-Year: +11.7%. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2000 to 2025.
What are CME's profit margins?
CME Group Inc. net profit margin is +62.0%, operating margin is +64.9%, and gross margin is +86.1%. Above-average net margins reflect strong pricing power and competitive moat. Return on Equity is +14.6%.
Is CME growing earnings?
Yes, CME earnings are accelerating — EPS growth of +15.4% exceeds the 5-year CAGR of +13.7%. TTM net income reached $4.2B. Earnings momentum is strengthening.
What was CME's best earnings year?
CME Group Inc.'s highest annual net income on record is $4.1B, achieved in fiscal year 2017. Earnings history on this page spans 2000 to 2025 and includes all annual and quarterly figures.
What were CME's earnings last quarter?
CME's most recent reported quarter was Q1 2026. Net income was $1.2B with diluted EPS of $3.18. For a full breakdown of all quarters, see the quarterly earnings table on this page.